Medical experts in Sheffield have hailed as a "game changer" trials of a drug that could reduce the recurrence of bladder ...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...
An FDA application for TAR-200 to treat BCG-unresponsive high-risk non-muscle-invasive bladder cancer is under real-time ...
THE CHOSUNILBO on MSN18h
South Korea’s FDA-approved Leclaza offers breakthrough in lung cancer survivalSouth Korea’s first domestically developed anti-cancer drug approved by the U.S. Food and Drug Administration (FDA), has ...
The most important take-home information from the INTERLACE trial is that in some people with cervical cancer that are ...
Cancer is a disease of the genome, according to Dr. Elli Papaemmanuil, computational oncologist at MSK. By looking at the ...
Colorectal cancer (CRC) is a type of cancer that begins in the colon (large intestine) or rectum, which are parts of the ...
Cancer therapies do not always succeed in eliminating tumor cells. Some of these cells enter a state of senescence—a latent, ...
While the announcement is good news for the Princess of Wales, cancer experts describe the challenges of a life shadowed by ...
One AI system based at Cambridge University used DNA data from The Cancer Genome Atlas to teach itself to identify early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback